Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation

被引：0
|
作者：
G. V. Ramesh Prasad
Jill Beckley
Mohit Mathur
Madhushankar Gunasekaran
Michelle M. Nash
Lindita Rapi
Michael Huang
Jeffrey S. Zaltzman
机构：
[1] University of Toronto,Kidney Transplant Program, St. Michael’s Hospital
[2] University of Toronto,Department of Medicine
来源：
BMC Infectious Diseases | / 19卷
关键词：
Adverse effects; Hyperkalemia; Leukopenia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Efficacy of trimethoprim-sulfamethoxazole for prophylaxis of Pneumocystis carinii pneumonia in patients with connective tissue disease.
    Okada, J
    Rana, M
    Kadoya, A
    Kondo, H
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 462 - 462
  • [22] Re-examination of Pneumocystis jirovecii Pneumonia During a Shortage of Parenteral Trimethoprim-Sulfamethoxazole
    Gupta, Purba
    Shinha, Takashi
    Pirouz, Ramin
    Lin, Yu Shia
    Gerolemou, Louis
    Sepkowitz, Dourglas
    CHEST, 2013, 144 (04)
  • [23] Low-dose trimethoprim-sulfamethoxazole for Pneumocystis jiroveci pneumonia prophylaxis after allogeneic hematopoietic SCT
    Muto, T.
    Takeuchi, M.
    Kawaguchi, T.
    Tanaka, S.
    Tsukamoto, S.
    Sakai, S.
    Takeda, Y.
    Abe, D.
    Ohwada, C.
    Sakaida, E.
    Shimizu, N.
    Yokote, K.
    Iseki, T.
    Nakaseko, C.
    BONE MARROW TRANSPLANTATION, 2011, 46 (12) : 1573 - 1575
  • [24] Reinstituting trimethoprim-sulfamethoxazole in patients receiving atovapuone for Pneumocystis carinii pneumonia prophylaxis
    James, CW
    McNelis, KC
    Szabo, S
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2003, 60 (15) : 1572 - 1574
  • [25] Twice weekly prophylaxis with trimethoprim/sulfamethoxazole for Pneumocystis jirovecii pneumonia in pediatric oncology patients
    Awad, Monica
    Sierra, Caroline M.
    Mesghali, Elhaam
    Bahjri, Khaled
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (08) : 1936 - 1939
  • [26] Treatment With Reduced-Dose Trimethoprim-Sulfamethoxazole Is Effective in Mild to Moderate Pneumocystis jirovecii Pneumonia in Patients With Hematologic Malignancies
    Hammarstrom, Helena
    Krifors, Anders
    Athlin, Simon
    Friman, Vanda
    Golestani, Karan
    Hallgren, Anita
    Otto, Gisela
    Oweling, Sara
    Pauksens, Karlis
    Kinch, Amelie
    Blennow, Ola
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (03) : E1252 - E1260
  • [27] Safety and efficacy evaluation of low-dose trimethoprim-sulfamethoxazole for prophylaxis of Pneumocystis pneumonia in HIV uninfected patients undergoing hemodialysis: a retrospective observational study
    Kanae Yamashita
    Yoshimitsu Shimomura
    Hiroaki Ikesue
    Nobuyuki Muroi
    Akihiro Yoshimoto
    Tohru Hashida
    BMC Infectious Diseases, 21
  • [28] Safety and efficacy evaluation of low-dose trimethoprim-sulfamethoxazole for prophylaxis of Pneumocystis pneumonia in HIV uninfected patients undergoing hemodialysis: a retrospective observational study
    Yamashita, Kanae
    Shimomura, Yoshimitsu
    Ikesue, Hiroaki
    Muroi, Nobuyuki
    Yoshimoto, Akihiro
    Hashida, Tohru
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [29] TRIMETHOPRIM-SULFAMETHOXAZOLE FOR THE TREATMENT OF PNEUMOCYSTIS-CARINII PNEUMONIA
    WINSTON, DJ
    LAU, WK
    GALE, RP
    YOUNG, LS
    ANNALS OF INTERNAL MEDICINE, 1980, 92 (06) : 762 - 769
  • [30] A dose-escalation regimen of trimethoprim-sulfamethoxazole is tolerable for prophylaxis against Pneumocystis jiroveci pneumonia in rheumatic diseases
    Takenaka, Kenchi
    Komiya, Yoji
    Ota, Mineto
    Yamazaki, Hayato
    Nagasaka, Kenji
    MODERN RHEUMATOLOGY, 2013, 23 (04) : 752 - 758
12345